Back to User profile » Dr Abdelbagi Alfadil
Papers published by Dr Abdelbagi Alfadil:
Synergistic Effects of Thymoquinone, 3-Hydrazinoquinoxaline-2-Thiol, and Amphotericin B Against Methicillin-Resistant Staphylococcus aureus: In vitro and in silico Evaluation
Ibrahem K, Alfadil A
International Journal of General Medicine 2026, 19:603479
Published Date: 25 May 2026
Burkholderia pseudomallei: A Multifaceted Threat and the Path Forward in Treatment and Prevention
Ibrahem K, Saleh BH, Alhussainy NH, Alsaedi A, Niyazi HA, Niyazi HA, Juma NA, Alqarni MA, Alfadil A, Sharif AT, Redwan B, Gazzaz M, Alharbi OS, Alhazmi KA, Altalhi R, Halabi WS, Almuhayya S, Aldehalan FA, Altarawneh H, Abu Lubad M, Bani Abdel-Rahman S, Alzoubi H, Alhazmi W, Alsufyani HA
Infection and Drug Resistance 2025, 18:5115-5127
Published Date: 25 September 2025
Antimicrobial Peptides: Mechanisms, Applications, and Therapeutic Potential
Alzain M, Daghistani H, Shamrani T, Almoghrabi Y, Daghistani Y, Alharbi OS, Sait AM, Mufrrih M, Alhazmi W, Alqarni MA, Saleh BH, Zubair MA, Juma NA, Niyazi HA, Niyazi HA, Halabi WS, Altalhi R, Kazmi I, Altayb HN, Ibrahem K, Alfadil A
Infection and Drug Resistance 2025, 18:4385-4426
Published Date: 27 August 2025
Repurposing the Anticancer Drug Cisplatin for Antibacterial Therapy: Evaluating Its Efficacy Against Pseudomonas aeruginosa Infections
Daghistani H, Attallah D, Alqarni MA, Saleh BH, Alhussainy NH, Sait AM, Mufrrih M, Alhazmi W, Alharbi OS, Alhazmi KA, Altalhi R, Halabi WS, Almuhayya S, Aldehalan FA, Altarawneh H, Abu Lubad M, Bani Abdel-Rahman SMS, Alfadil A, Ibrahem K
Infection and Drug Resistance 2025, 18:4179-4186
Published Date: 19 August 2025
Epidemiology and Clinical Impact of Vancomycin-Resistant Enterococcus at King Abdulaziz University Hospital (2015–2022): Prevalence, Risk Factors, and Mortality
Mokhtar JA, Attallah D, Al-Rabia MW, Alqarni MA, Alkuwaity KK, Almoghrabi Y, Daghistani H, Ismail MA, Sharif AT, Redwan B, Ajabnoor AM, Alharbi OS, Abu IM, Alhazmi W, Mufrrih M, Sait AM, Alfadil A, Daghistani Y, Momin HJ, Ibrahem K
International Journal of General Medicine 2025, 18:2021-2031
Published Date: 8 April 2025
Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia
Mokhtar JA, Attallah DM, Jiman-Fatani AA, Al-Rabia MW, Alqarni MA, Saleh BH, Amboon MM, Altorki TA, Alkuwaity KK, Abujamel T, Kaki R, Albarakati TN, Daghistani H, Ismail MA, Alharbi O, Abu ITM, Alfadil A, Ibrahem K, Mufrrih M, Sait AM
International Journal of General Medicine 2025, 18:627-641
Published Date: 7 February 2025
Epidemiological and Clinical Insights into Acinetobacter baumannii: A Six-Year Study on Age, Antibiotics, and Specimens
Almoghrabi Y, Daghistani H, Niyazi HA, Niyazi HA, AbdulMajed H, Juma NA, Daffa N, Helmi NR, Al-Rabia MW, Mokhtar JA, Saleh BH, Attallah DM, Matar M, Shukri HA, Moqaddam SA, Alamoudi S, Alkuwaity KK, Abujamel T, Sait AM, Mufrrih M, Al-Zahrani IA, O’hagan S, Ismail MA, Alharbi OS, Momin HJ, Abu IM, Alfadil A, Ibrahem K
International Journal of General Medicine 2024, 17:5715-5725
Published Date: 3 December 2024
The Combination of 3-Hydrazinoquinoxaline-2-Thiol with Thymoquinone Demonstrates Synergistic Activity Against Different Candida Strains
Bazuhair MA, Alsieni M, Abdullah H, Mokhtar JA, Attallah D, Abujamel TS, Alkuwaity KK, Niyazi HA, Niyazi HA, AbdulMajed H, Juma N, Al-Rabia MW, Alfadil A, Ibrahem K
Infection and Drug Resistance 2024, 17:2289-2298
Published Date: 6 June 2024
The Prevalence and Risk Factors of Trichosporonosis at King Abdulaziz University Hospital
Alboloshi GJ, Jiman-Fatani AA, Attallah D, Mokhtar JA, Al-Abdullah NA, Alkuwaity K, Kaki R, Al-Rabia MW, Alfadil A, Ibrahem K, Teklemariam AD, Harakeh S
International Journal of General Medicine 2024, 17:1297-1310
Published Date: 3 April 2024
Gastroprotective Effect of 2,3-Dimethylquinoxaline Against Indomethacin-Induced Gastric Ulcer in Rat
Alfadil A
Journal of Inflammation Research 2024, 17:1983-1994
Published Date: 29 March 2024
Synergistic Activity of 3-Hydrazinoquinoxaline-2-Thiol in Combination with Penicillin Against MRSA
Elfadil A, Ibrahem K, Abdullah H, Mokhtar JA, Al-Rabia MW, Mohammed HA
Infection and Drug Resistance 2024, 17:355-364
Published Date: 31 January 2024
Evaluation of the Antibacterial Activity of Quinoxaline Derivative Compound Against Methicillin-Resistant Staphylococcus aureus
Elfadil A, Alzahrani AM, Abdullah H, Alsamhan H, Abujamel TS, Ahmed HE, Jiman-Fatani A
Infection and Drug Resistance 2023, 16:2291-2296
Published Date: 18 April 2023
